131 related articles for article (PubMed ID: 3516541)
1. [The control of bronchial secretions in chronic hypersecretory bronchopneumopathies: the role of letosteine].
Morandini G; Finiguerra M; Fraticelli G; Ferraris F; Gallone F
Clin Ter; 1986 Feb; 116(3):179-93. PubMed ID: 3516541
[No Abstract] [Full Text] [Related]
2. [Drugs active on mucus in the primary treatment of chronic bronchitis. Controlled study of the activity of letosteine].
Cremonini C; Spada E; Cellini F; Cioni R; Giovannini M; Perri G; Priolo U; Fraticelli G; Gusmitta A
Clin Ter; 1986 Jan; 116(2):121-9. PubMed ID: 3516537
[No Abstract] [Full Text] [Related]
3. [A new contribution to the treatment of chronic bronchopneumopathies: letosteine].
Macquet V; Ficheroulle X; Ta Van P; Peltier M
Lille Med; 1979 Nov; 24(9):735-8. PubMed ID: 529981
[No Abstract] [Full Text] [Related]
4. [Letosteine in chronic obstructive bronchopneumopathy].
Meroni P; Palmieri G; De Bartolo G; Barcellini W; Albrici A; Froldi M
Clin Ter; 1983 Apr; 105(2):109-18. PubMed ID: 6345052
[No Abstract] [Full Text] [Related]
5. [Clinical evaluation of letosteine activity in the treatment of acute febrile bronchitis in children. Double-blind controlled study versus placebo].
Nespoli L; Monafo V; Bonetti F; Terracciano L; Savio G
Minerva Pediatr; 1989 Oct; 41(10):515-20. PubMed ID: 2693929
[TBL] [Abstract][Full Text] [Related]
6. [Comparative clinical evaluation of two mucolytic agents: S-carboxy-methyl-cysteine and letosteine (author's transl)].
Blaive B; Lapalus P; Lemoigne F
Sem Hop; 1978 Oct 8-15; 54(29-32):983-6. PubMed ID: 216094
[TBL] [Abstract][Full Text] [Related]
7. No demonstrable effect of sobrerol as an expectorant in patients with stable chronic bronchial diseases.
Medici TC; Shang H; Grosgurin P; Berg P; Achermann R; Wehrli R
Bull Eur Physiopathol Respir; 1985; 21(6):477-83. PubMed ID: 3907738
[TBL] [Abstract][Full Text] [Related]
8. Rheological profile of nesosteine: a new mucoactive agent.
Braga PC; Beghi G; Castelli C; Grasselli G; Ornaghi A; Rampoldi C; Zheng Y; Allegra L
Int J Clin Pharmacol Res; 1989; 9(1):77-83. PubMed ID: 2707929
[TBL] [Abstract][Full Text] [Related]
9. [Effect of letosteine on muco-ciliary transport in patients with chronic bronchopathy].
Olivieri D; Del Donno M; Schettini A
Arch Monaldi; 1983; 38(3):105-12. PubMed ID: 6675560
[No Abstract] [Full Text] [Related]
10. [Drug therapy of bronchosecretolytic disorders].
Schmidt OP
Med Klin; 1977 Feb; 72(5):145-60. PubMed ID: 321928
[No Abstract] [Full Text] [Related]
11. [Contribution to the treatment of serous or purulent bronchial hypersecretion in acute and chronic bronchopneumopathies].
Baracco F; Repetto E; Giordano L
Minerva Med; 1969 Sep; 60(75):3509-13. PubMed ID: 5344811
[No Abstract] [Full Text] [Related]
12. [Therapeutic efficacy and general tolerability of 4-carbomethoxythiazolidine chlorohydrate in adult patients with hypersecretory bronchopulmonary diseases].
Campisi U; Sciutto L; Patti S
Boll Chim Farm; 1990; 129(10-11):56S-59S. PubMed ID: 2102703
[TBL] [Abstract][Full Text] [Related]
13. Mucoid impaction of the bronchi.
Urschel HC; Paulson DL; Shaw RR
Ann Thorac Surg; 1966 Jan; 2(1):1-16. PubMed ID: 5924799
[No Abstract] [Full Text] [Related]
14. [Treatment of serous and puruloid bronchial hypersecretions in acute and chronic bronchopneumopathies: our experience with a new mucolytic drug].
Fossati C
Clin Ter; 1975 Jul; 74(1):63-82. PubMed ID: 770054
[No Abstract] [Full Text] [Related]
15. [Correction of mucociliary insufficiency: present-day modalities and perspectives].
Ter Arkh; 2006; 78(3):74-84. PubMed ID: 17019964
[No Abstract] [Full Text] [Related]
16. [Controlled clinical study of the therapeutic activity of arginine thiazolidine carboxylate in patients with chronic toxic and postinfective hepatopathies].
Salsano F; Ciancarelli MP
Minerva Dietol Gastroenterol; 1979; 25(4):391-8. PubMed ID: 400006
[No Abstract] [Full Text] [Related]
17. Review on sobrerol as a muco-modifying drug: experimental data and clinical findings in hypersecretory bronchopulmonary diseases.
Braga PC; Allegra L; Bossi R; Scuri R; Castiglioni CL; Romandini S
Int J Clin Pharmacol Res; 1987; 7(5):381-400. PubMed ID: 3312046
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the activity of the carbocysteine-sobrerol combination on mucus spinnability.
Distefano SM; Palermo F; Crimi N; Mistretta A; Pamparana F; Messa A
Int J Clin Pharmacol Res; 1988; 8(1):31-5. PubMed ID: 3284830
[TBL] [Abstract][Full Text] [Related]
19. [Bisolvon in pneumological practice].
Ollagnier C; Vallon MC
Lyon Med; 1969 Dec; 222(46):1233-5. PubMed ID: 4905093
[No Abstract] [Full Text] [Related]
20. Effects of seaprose on the rheology of bronchial mucus in patients with chronic bronchitis. A double-blind study vs placebo.
Braga PC; Moretti M; Piacenza A; Montoli CC; Guffanti EE
Int J Clin Pharmacol Res; 1993; 13(3):179-85. PubMed ID: 8225701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
